Clinical trial
Multiple Dose ASM8 in Mild Asthmatics
NCT00264966 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00264966 |
|---|---|
| Title | Multiple Dose ASM8 in Mild Asthmatics |
| Official title | A Double-blind, Placebo-controled, Crossover Study To Evaluate the Efficacy, Safety and Tolerability of Inhaled ASM8-003 in Subjects With Mild Allergic Asthma. |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | ASM8 |
| Enrollment | 15 |
| Start date | Dec 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Dec 13, 2005 |
| Last update posted | Dec 3, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: